Overview

Gender

male

Investor Type

Investment Partner

Steven J. Kafka (PhD) is the Chief Business Officer at Foundation Medicine Inc.

Steven Kafka joined Foundation Medicine in January 2013, bringing over 15 years of business and strategy experience in the pharmaceutical and biotechnology industries, with a focus on targeted therapies in oncology.

Steven Kafka was previously Chief Operating Officer and Chief Financial Officer at Aileron Therapeutics, where he led the company's operations, finance, and human resources functions, and helped to secure a major collaboration with Roche worth up to $1.1 billion.

Before this, Steven Kafka was vice president of finance at Infinity Pharmaceuticals (NASDAQ: INFI) where he led finance, investor and public relations and business operations. While at Infinity, he worked on a number of innovative collaborations with leading pharmaceutical companies, including the company’s strategic alliance with Purdue Pharmaceuticals.

Earlier in his career, Steven Kafka was Senior Director of Finance at Millennium Pharmaceuticals, where he was a key member of the product team in driving strategic planning and alliance management efforts with partner Johnson & Johnson for VELCADE®, a novel targeted cancer therapeutic.

Steven Kafka earned his Ph.D. from Harvard University.

His B.A. with Distinction and Honors from Stanford University.